NCT06222931

Brief Summary

Postmenopausal women suffer from a series of negative health factors, such as decreased bone and muscle mass and physical performance, increasing the risk of falls and decreasing quality of life. Therefore, intervention strategies aimed at mitigating these factors are essential. A technique that has been studied and can reverse these factors is whole-body vibration (WBV), however studies present contradictory results and the main confounding factor appears to be related to the type of vibration (synchronous or side-alternating). Therefore, the primary objective of this project is to verify the effects of 12 months of whole-body vibration on different devices on bone mineral density measurements in postmenopausal women. As a secondary objective, the effects on muscle mass, physical performance, quality of life and falls will be verified. 228 postmenopausal women will participate in the study and will be randomized to: triplanar vibration (synchronous); side-alternating vibration; or false vibration. The interventions will last 12 months and will occur three times a week on non-consecutive days. The following assessments will be carried out at baseline, 6-months and 12-months: bone mineral density and muscle mass by DXA equipment, muscle thickness by ultrasound, peak torque of the knee extensor and flexor muscles by an isokinetic dynamometer, hand grip, balance static postural and vertical jump on a force platform, dynamic balance using the Timed Up and Go test, SPPB battery, fear (FES-I) and incidence of falls and quality of life (SF-36).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
228

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 25, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

January 25, 2024

Status Verified

January 1, 2024

Enrollment Period

1.5 years

First QC Date

January 15, 2024

Last Update Submit

January 15, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Bone mineral density

    Bone mineral density of the lumbar spine, total hip, femoral neck and trochanter assessed by DXA, expressed in g/cm2

    Baseline (pre-intervention), 6-months and 12-months

  • Appendicular skeletal muscle mass

    Appendicular skeletal muscle mass assessed by DXA, expressed in kg/m2

    Baseline (pre-intervention), 6-months and 12-months

Secondary Outcomes (9)

  • Muscle thickness

    Baseline (pre-intervention), 6-months and 12-months

  • Physical Performance

    Baseline (pre-intervention), 6-months and 12-months

  • Dynamic balance

    Baseline (pre-intervention), 6-months and 12-months

  • Hand grip strength

    Baseline (pre-intervention), 6-months and 12-months

  • Static postural balance

    Baseline (pre-intervention), 6-months and 12-months

  • +4 more secondary outcomes

Study Arms (3)

Triplanar Vibration (synchronous)

EXPERIMENTAL

Triplanar vibration, performed at 25 Hz and 4 mm peak-to-peak displacement, for 5 minutes each session, three times a week. Participants will be positioned standing, with knees semi-flexed at 30º.

Device: Triplanar vibrating platform

Side-alternating vibration

EXPERIMENTAL

Vibration with alternating side of the base, performed at 25 Hz and 4 mm peak-to-peak displacement, for 5 minutes each session, three times a week. Participants will be positioned standing, with knees semi-flexed at 30º.

Device: Side-alternating vibrating platform

False vibration

SHAM COMPARATOR

Platform identical to the other two used by the experimental groups, configured at 25 Hz, however, without peak-to-peak displacement. The platform starts the engine and emits an operating sound identical to a vibrating platform in operation, but does not generate any mechanical vibration. Participants will be positioned standing, with knees semi-flexed at 30º and must remain on the equipment for 5 minutes each session, three times a week.

Other: Sham vibration

Interventions

Mechanical vibration emitted by triplanar vibrating platforms

Triplanar Vibration (synchronous)

Mechanical vibration emitted by side-alternating vibrating platforms

Side-alternating vibration

Simulated vibration

False vibration

Eligibility Criteria

Age50 Years - 80 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being postmenopausal (without menstruating for at least 12 months);
  • Not performing physical exercise systematically for at least 6 months;
  • Not needing assistance to carry out daily tasks;
  • Do not present serious cognitive problems that make it impossible to understand simple commands;
  • Do not have serious dysfunctions or implants in the spine, hips or lower limbs;
  • Not have neurological diseases or diseases that affect bone metabolism;
  • Do not have vascular diseases, arrhythmia, use a pacemaker, suffer from epilepsy or seizures;
  • No diseases/problems that affect the retina;
  • Do not present severe labyrinthitis or vertigo;
  • Not using medication/supplements to increase bone and/or muscle mass for at least 6 months;
  • Have not undergone cancer treatment in the last 5 years.

You may not qualify if:

  • Withdraw from participating in the study for any reason;
  • Present adverse events during interventions that cannot be controlled.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Estadual do Norte do Paraná

Jacarezinho, Paraná, 86400-000, Brazil

RECRUITING

Central Study Contacts

Raphael G de Oliveira, PhD

CONTACT

Laís C de Oliveira, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 15, 2024

First Posted

January 25, 2024

Study Start

January 15, 2024

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

January 25, 2024

Record last verified: 2024-01

Locations